SCHEMBL18921933

SCHEMBL18921933

CPn1nc(C)c2cc(Nc3ccc(N4CCN(C)CC4)c(F)c3)cnc21

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 2/20 0.52
▸ JAK2 O60674 6/20 0.46
▸ PDE7A Q13946 3/20 0.42
▸ FLT3 P36888 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ BRD4 O60885 6/20 0.41
▸ JAK3 P52333 2/20 0.41
▸ BRDT Q58F21 2/20 0.41
▸ BRD2 P25440 1/20 0.41
▸ BRD3 Q15059 1/20 0.41
▸ BTK Q06187 1/20 0.41
▸ JAK1 P23458 2/20 0.41
▸ CSF1R P07333 1/20 0.40
▸ CDK4 P11802 1/20 0.40
▸ CDK6 Q00534 1/20 0.40
▸ PAK1 Q13153 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18921934 0.78 AXL (0.45) AXLJAK2FLT3JAK3
SCHEMBL12965947 0.78 JAK2 (0.46) AXLJAK2PDE7AFLT3JAK3
SCHEMBL12965679 0.78 AXL (0.52) AXLJAK2PDE7AFLT3KDM4E
SCHEMBL18921936 0.71 MAP4K1 (0.51) —
SCHEMBL29469944 0.70 AXL (0.55) AXLJAK2FLT3KDM4EBRD4
SCHEMBL21677035 0.70 AXL (0.47) AXLJAK2FLT3BRD4JAK3
SCHEMBL15805375 0.69 JAK2 (0.45) AXLJAK2FLT3KDM4EBRD4
SCHEMBL15805447 0.68 JAK2 (0.49) AXLJAK2FLT3JAK3BTK
SCHEMBL21677036 0.68 CLK1 (0.45) AXLJAK2FLT3KDM4EBRD4
SCHEMBL15805363 0.68 AXL (0.47) AXLJAK2BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9962382-B2 Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors ARRIEN PHARMACEUTICALS LLC (US) 2018-05-08 — — US disclosed
US-9669028-B2 Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors ARRIEN PHARMACEUTICALS LLC (US) 2017-06-06 — — US disclosed
Send feedback